Verastem Inc (VSTM) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Verastem Inc   (NASDAQ: VSTM)
 

Verastem Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Verastem Inc 's inventory turnover ratio sequentially decreased to 0.54 in the second quarter 2026, unsurprisingly, as the Verastem Inc markets continue to deteriorate, and VSTM's faces growing challenges to bring down its inventories. Verastem Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 676 days, from 664 days, in the Mar 31 2026 quarter.

Within Healthcare sector 352 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1659 in the first quarter 2026, to 1913.

VSTM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Verastem Inc Market Share?

What is Inventory Turnover Ratio?




VSTM Inventory Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 105.14 % - - - -
Y / Y Cost of Sales Growth 117.97 % - - - -
Inventory Turnover Ratio (TTM) 0.54 0.55 0.58 0.56 0.44
VSTM's Total Ranking # 1913 # 1659 # 0 # 0 # 0
Average inventory processing period 672 661 627 647 833
Seq. Inventory Growth 4.77 % 24.77 % 2.17 % 53.6 % -
Seq. Cost of Sales Growth 0 % -0.36 % -3.45 % 126.56 % -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 111
Healthcare Sector # 353
Overall Market # 1913

Inventory Turnover Ratio Statistics
High Average Low
3.8 1.59 0.44
(Sep 30 2019)   (Jun 30 2020)




Financial Statements
Verastem Inc 's Inventories $ 2 Millions Visit VSTM's Balance sheet
Verastem Inc 's Cost of Revenues TTM $ 1 Millions Visit VSTM's Income Statement
What are VSTM's Sales? Visit VSTM's Sales by Segment

Other Inventory Turnover Ratios
Verastem Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
VSTM's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for VSTM's Competitors
Inventory Turnover Ratio for VSTM's Suppliers
Inventory Turnover Ratio for VSTM's Customers

You may also want to know
VSTM's Sales Growth Rates VSTM's Pe Price to earnings ratio VSTM's Receivables Turnover Ratio VSTM's Stock Quote
VSTM's Net Income Growth Rates VSTM's Ps Price to Sales ratio VSTM's Sales per Employee VSTM's Asset Turnover Ratio
VSTM's Net Margin VSTM's Pb Price to Book ratio VSTM's Financial Strength Ratios VSTM's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Elanco Animal Health Incorporated  1.29 $ 2,241.000  Millions$ 1,733  Millions
Xtant Medical Holdings Inc   1.28 $ 43.701  Millions$ 34  Millions
Edwards Lifesciences Corporation  1.28 $ 1,443.400  Millions$ 1,129  Millions
Globus Medical Inc   1.27 $ 989.145  Millions$ 779  Millions
Karyopharm Therapeutics Inc   1.27 $ 4.942  Millions$ 4  Millions
Clene Inc   1.25 $ 0.059  Millions$ 0  Millions
Si bone inc   1.24 $ 44.462  Millions$ 36  Millions
Kyntra Bio Inc   1.24 $ 4.444  Millions$ 4  Millions
Astrotech Corp  1.24 $ 0.696  Millions$ 1  Millions
Pulmonx Corporation  1.24 $ 20.014  Millions$ 16  Millions
Biolife Solutions Inc   1.24 $ 39.035  Millions$ 32  Millions
Stereotaxis Inc   1.23 $ 13.184  Millions$ 11  Millions
60 Degrees Pharmaceuticals Inc   1.20 $ 0.895  Millions$ 1  Millions
Neuropace Inc   1.18 $ 19.930  Millions$ 17  Millions
Delcath Systems Inc   1.16 $ 12.355  Millions$ 11  Millions
Bridgebio Pharma Inc   1.16 $ 39.655  Millions$ 34  Millions
Amarin Corp Plcuk  1.13 $ 108.346  Millions$ 96  Millions
Penumbra Inc  1.11 $ 483.975  Millions$ 436  Millions
Zimmer Biomet Holdings Inc   1.10 $ 2,563.400  Millions$ 2,322  Millions
Treace Medical Concepts Inc   1.10 $ 42.186  Millions$ 38  Millions
Corcept Therapeutics Inc  1.10 $ 14.085  Millions$ 13  Millions
Zoetis Inc   1.08 $ 2,709.000  Millions$ 2,513  Millions
Acadia Pharmaceuticals Inc   1.07 $ 100.979  Millions$ 94  Millions
Beone Medicines Ltd   1.07 $ 680.530  Millions$ 639  Millions
Bio Green Med Solution Inc   1.07 $ 1.244  Millions$ 1  Millions
Hyperfine Inc   1.06 $ 6.924  Millions$ 7  Millions
Pacira Biosciences inc   1.04 $ 155.154  Millions$ 149  Millions
Humacyte Inc   1.03 $ 12.611  Millions$ 12  Millions
Vertex Pharmaceuticals Inc  1.03 $ 1,762.800  Millions$ 1,711  Millions
Tg Therapeutics Inc   1.03 $ 140.939  Millions$ 137  Millions

Date modified: 2026-09-26T07:14:04+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.